Karen T. Tashima, MD

Clinical Research Site Leader
The Miriam Hospital

Disclosure: Bristol-Myers Squibb (Individual(s) Involved: Self): Research Grant or Support; Gilead Sciences Inc. (Individual(s) Involved: Self): Grant/Research Support, Scientific Research Study Investigator; GlaxoSmithKline (Individual(s) Involved: Self): Research Grant or Support; Merck (Individual(s) Involved: Self): Research Grant or Support; Tibotec (Individual(s) Involved: Self): Research Grant or Support; Viiv Healthcare (Individual(s) Involved: Self): Research Grant or Support

Presentation(s):

• 72 - Remdesivir vs Standard Care in Patients with Moderate covid-19

  Oral Abstract

• 73 - Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir

  Oral Abstract